RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Paul Wang to Drug Carriers

This is a "connection" page, showing publications Paul Wang has written about Drug Carriers.
Connection Strength

0.384
  1. Zhuang X, Ma X, Xue X, Jiang Q, Song L, Dai L, Zhang C, Jin S, Yang K, Ding B, Wang PC, Liang XJ. A Photosensitizer-Loaded DNA Origami Nanosystem for Photodynamic Therapy. ACS Nano. 2016 Mar 22; 10(3):3486-95.
    View in: PubMed
    Score: 0.126
  2. Zhang J, Li S, An FF, Liu J, Jin S, Zhang JC, Wang PC, Zhang X, Lee CS, Liang XJ. Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug release. Nanoscale. 2015 Aug 28; 7(32):13503-10.
    View in: PubMed
    Score: 0.121
  3. Kumar A, Chen F, Mozhi A, Zhang X, Zhao Y, Xue X, Hao Y, Zhang X, Wang PC, Liang XJ. Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation. Nanoscale. 2013 Sep 21; 5(18):8307-8325.
    View in: PubMed
    Score: 0.106
  4. Tuguntaev RG, Okeke CI, Xu J, Li C, Wang PC, Liang XJ. Nanoscale Polymersomes as Anti-Cancer Drug Carriers Applied for Pharmaceutical Delivery. Curr Pharm Des. 2016; 22(19):2857-65.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support